Literature DB >> 6873145

Pharmacokinetics of gentamicin in very low birth weight preterm infants.

K W Hindmarsh, R L Nation, G L Williams, E John, J N French.   

Abstract

Low birth weight preterm infants with suspected infection were administered gentamicin intramuscularly every 18 h (2.5 mg/kg) or 24 h (3.0 mg/kg). For both dosage regimens plasma gentamicin levels were monitored during a dosage interval on three separate occasions over a 10 day period. Both regimens gave satisfactory plasma concentrations and there was no important statistically significant difference between the two. The body clearance of gentamicin correlated with gestational age (r = 0.76, p less than 0.01). The results indicate either regimen may be useful in the clinical situation but from a practical standpoint administration every 24 h may be easier to comply with then every 18 h.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873145     DOI: 10.1007/bf00542216

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Concentrations of gentamicin and amikacin in human kidneys.

Authors:  C Q Edwards; C R Smith; K L Baughman; J F Rogers; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

2.  A growth chart for premature and other infants.

Authors:  D Gairdner; J Pearson
Journal:  Arch Dis Child       Date:  1971-12       Impact factor: 3.791

3.  Urinary excretion of gentamicin in the neonatal period.

Authors:  G H McCracken; N R West; L J Horton
Journal:  J Infect Dis       Date:  1971-03       Impact factor: 5.226

4.  Clinical assessment of gestational age in the newborn infant.

Authors:  L M Dubowitz; V Dubowitz; C Goldberg
Journal:  J Pediatr       Date:  1970-07       Impact factor: 4.406

5.  Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates.

Authors:  S J Szefler; R J Wynn; D F Clarke; S Buckwald; D Shen; J J Schentag
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

6.  Gentamicin dosage in preterm and term neonates.

Authors:  B M Assael; V Gianni; A Marini; P Peneff; F Sereni
Journal:  Arch Dis Child       Date:  1977-11       Impact factor: 3.791

7.  Gentamicin and albumin-bilirubin binding. An in vivo study.

Authors:  J T Woods; L E Bryan; G Chan; D Schiff
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

8.  Multiexponential elimination of gentamicin. A kinetic study during development.

Authors:  B M Assael; G Cavanna; W J Jusko; A Marini; R Parini; F Sereni; A Viganò
Journal:  Dev Pharmacol Ther       Date:  1980

9.  Two-compartment gentamicin pharmacokinetics in premature neonates: a comparison to adults with decreased glomerular filtration rates.

Authors:  D B Haughey; D M Hilligoss; A Grassi; J J Schentag
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

Review 10.  Antimicrobial therapy and the neonate.

Authors:  S J Yaffe
Journal:  Obstet Gynecol       Date:  1981-11       Impact factor: 7.661

View more
  13 in total

1.  Pharmacokinetics and antibacterial activity of daily gentamicin.

Authors:  H Skopnik; R Wallraf; B Nies; K Tröster; G Heimann
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

Review 2.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

3.  Neonatal pharmacology--a practical approach.

Authors:  D A MacKintosh
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

Review 4.  Clinical pharmacokinetics of antibacterial drugs in neonates.

Authors:  C M Paap; M C Nahata
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

5.  Gentamicin interval in newborn infants as determined by renal function and postconceptional age.

Authors:  L P Brion; A R Fleischman; G J Schwartz
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

6.  Estimation of gentamicin clearance and volume of distribution in neonates and young children.

Authors:  A W Kelman; A H Thomson; B Whiting; S M Bryson; D A Steedman; G E Mawer; L A Samba-Donga
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of aminoglycosides in the neonate: a review.

Authors:  Gian Maria Pacifici
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953

Review 8.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

Review 9.  Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries.

Authors:  Gary L Darmstadt; Mary Miller-Bell; Maneesh Batra; Paul Law; Kiely Law
Journal:  J Health Popul Nutr       Date:  2008-06       Impact factor: 2.000

10.  Simplified dosing of gentamicin for treatment of sepsis in Bangladeshi neonates.

Authors:  M Monir Hossain; Nazma A Chowdhury; Mahfuza Shirin; Samir K Saha; Mary Miller-Bell; David Edwards; Jacob Aranda; Patricia Coffey; Gary L Darmstadt
Journal:  J Health Popul Nutr       Date:  2009-10       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.